Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45+
SponsorUniversitätsklinikum Hamburg-Eppendorf

About this trial

INDUCT-Multi is a multicenter randomized trial investigating whether continuous, compared to bolus, administration of norepinephrine during induction of general anesthesia reduces postinduction hypotension in high-risk non-cardiac surgery patients.

Eligibility criteria

Qualifiers

Age ≥65 years

ASA physical status III or IV

Chronic arterial hypertension

Diabetes mellitus requiring medication

Disqualifiers

Pregnancy

Cardiac arrhythmia

History of intracranial hemorrhage or intracranial aneurysm

Clinical indication for continuous norepinephrine infusion during induction of general anesthesia (e.g., severe aortic valve stenosis, coronary artery disease, or heart failure)

Trial design

Treatments tested in this trial

  • Continuous Norepinephrine Administration

Treatment groups

446 Participants
are divided into 2 treatment groups